- Home
- SLNO vs INSP Comparison
SLNO vs INSP Comparison
Compare SLNO & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- INSP
- Stock Information
- Founded
- SLNO 1999
- INSP 2007
- Country
- SLNO United States
- INSP United States
- Employees
- SLNO N/A
- INSP N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INSP Medical/Dental Instruments
- Sector
- SLNO Health Care
- INSP Health Care
- Exchange
- SLNO Nasdaq
- INSP Nasdaq
- Market Cap
- SLNO 3.8B
- INSP 3.8B
- IPO Year
- SLNO 2014
- INSP 2018
- Fundamental
- Price
- SLNO $68.57
- INSP $96.04
- Analyst Decision
- SLNO Strong Buy
- INSP Buy
- Analyst Count
- SLNO 10
- INSP 14
- Target Price
- SLNO $112.50
- INSP $167.08
- AVG Volume (30 Days)
- SLNO 1.6M
- INSP 1.7M
- Earning Date
- SLNO 08-06-2025
- INSP 08-04-2025
- Dividend Yield
- SLNO N/A
- INSP N/A
- EPS Growth
- SLNO N/A
- INSP 756.73
- EPS
- SLNO N/A
- INSP 1.74
- Revenue
- SLNO $32,656,999.00
- INSP $861,312,000.00
- Revenue This Year
- SLNO N/A
- INSP $20.61
- Revenue Next Year
- SLNO $209.31
- INSP $17.32
- P/E Ratio
- SLNO N/A
- INSP $52.59
- Revenue Growth
- SLNO N/A
- INSP 22.05
- 52 Week Low
- SLNO $41.50
- INSP $73.92
- 52 Week High
- SLNO $90.32
- INSP $225.00
- Technical
- Relative Strength Index (RSI)
- SLNO 32.58
- INSP 43.25
- Support Level
- SLNO $66.72
- INSP $82.68
- Resistance Level
- SLNO $87.17
- INSP $88.72
- Average True Range (ATR)
- SLNO 3.81
- INSP 5.39
- MACD
- SLNO -1.52
- INSP 1.53
- Stochastic Oscillator
- SLNO 21.55
- INSP 99.86
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.